Clinical trials
Not yet recruiting Phase 1 Diabetes Mellitus, Type 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fujian Shengdi Pharmaceutical Co., Ltd. | 2 |
| Addpharma Inc. | 1 |
| Autotelicbio | 1 |
| Biolexis Therapeutics | 1 |
| Chendu DIAO Pharmaceutical Group CO., LTD. | 1 |
| Chipscreen Biosciences, Ltd. | 1 |
| Fujian Medical University Union Hospital | 1 |
| Gan & Lee Pharmaceuticals. | 1 |
| Gan and Lee Pharmaceuticals, USA | 1 |
| Hangzhou Reprogenix Bioscience, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 15 |
| Obesity | 2 |
| Diabetes Mellitus | 1 |
| Hyperlipidemias | 1 |
| Hypertension | 1 |
| Metabolic Diseases | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
| Overweight | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.